BLMN vs TSLA

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a lack of Altman Z-Score raises concerns about bankruptcy risk assessment. Despite a high dividend yield of 7.83%, the unsustainable payout ratio of 186.49% and negative profitability metrics signal severe earnings pressure. Valuation multiples appear deceptively attractive due to low P/E and P/S ratios, but these are distorted by weak or negative margins and declining earnings. The technical trend is bearish, insider activity shows net selling, and long-term price performance remains deeply negative, reinforcing a high-risk profile.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.